Wells Fargo & Company Adaptive Biotechnologies Corp Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 53,812 shares of ADPT stock, worth $272,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,812

Previous 38,523 39.69%

Holding current value

$272,288

Previous $123,000 57.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $35,776 - $60,544	15,289 Added 39.69%	53,812 $194,000
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $11,937 - $19,896	4,145 Added 12.06%	38,523 $123,000
Q4 2023 Feb 09, 2024	BUY	$3.46 - $5.33 $23,988 - $36,952	6,933 Added 25.26%	34,378 $168,000
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $113,426 - $188,819	-22,372 Reduced 44.91%	27,445 $149,000
Q2 2023 Aug 15, 2023	BUY	$6.19 - $8.78 $102,425 - $145,282	16,547 Added 49.74%	49,817 $334,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $71,869 - $93,153	9,214 Added 38.3%	33,270 $293,000
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $5,108 - $7,621	-816 Reduced 3.28%	24,056 $183,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $65,338 - $127,358	-10,052 Reduced 28.78%	24,872 $178,000
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $4,345 - $10,001	-679 Reduced 1.91%	34,924 $283,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $122,330 - $349,343	12,088 Added 51.41%	35,603 $493,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $84,973 - $124,405	-3,376 Reduced 12.55%	23,515 $660,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $253,669 - $336,901	-8,450 Reduced 23.91%	26,891 $915,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $25.2 Million - $34.8 Million	-781,117 Reduced 95.67%	35,341 $1.44 Million
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $19.4 Million - $35.3 Million	-521,369 Reduced 38.97%	816,458 $32.9 Million
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $10.6 Million - $15.4 Million	234,854 Added 21.29%	1,337,827 $79.1 Million
Q3 2020 Nov 05, 2020	BUY	$35.79 - $48.81 $6.86 Million - $9.36 Million	191,746 Added 21.04%	1,102,973 $53.6 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $656,010 - $1.27 Million	26,293 Added 2.97%	911,227 $44.1 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $15 Million - $30.2 Million	884,934 New	884,934 $24.6 Million

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $723M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Adaptive Biotechnologies Corp Transaction History